Activity of clarithromycin and its principal human metabolite against Haemophilus influenzae (Q36754391)

16 August 2017

Activity of clarithromycin and its principal human metabolite against Haemophilus influenzae (English)

1 reference

16 August 2017

1 reference

Haemophilus influenzae

object named as

Haemophilus influenzae

1 reference

1 reference

10.1128/AAC.35.7.1524

https://api.crossref.org/works/10.1128/AAC.35.7.1524

5 December 2022

author name string

J. H. Jorgensen

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1834012

5 December 2022

L. A. Maher

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1834012

5 December 2022

A. W. Howell

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1834012

5 December 2022

language of work or name

English

0 references

publication date

1 July 1991

1 reference

PMC publication ID

245208

full work available at URL

16 August 2017

https://europepmc.org/articles/PMC245208

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1834012

https://europepmc.org/articles/PMC245208?pdf=render

5 December 2022

file format

Portable Document Format

online access status

open access

content deliverer

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1834012

https://journals.asm.org/doi/pdf/10.1128/AAC.35.7.1524

5 December 2022

1 reference

Crossref

DOI

10.1128/AAC.35.7.1524

https://api.crossref.org/works/10.1128/AAC.35.7.1524

Antimicrobial Agents and Chemotherapy

5 December 2022

published in

1 reference

16 August 2017

35

1 reference

16 August 2017

7

1 reference

16 August 2017

1524-1526

1 reference

Improved medium for antimicrobial susceptibility testing of Haemophilus influenzae

16 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=245208

Disk diffusion susceptibility testing of two macrolide antimicrobial agents: revised interpretive criteria for erythromycin and preliminary guidelines for roxithromycin (RU 965).

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=245208

Enhancement of the in vitro and in vivo activities of clarithromycin against Haemophilus influenzae by 14-hydroxy-clarithromycin, its major metabolite in humans

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=245208

Antimicrobial resistance among respiratory isolates of Haemophilus influenzae, Moraxella catarrhalis, and Streptococcus pneumoniae in the United States

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=245208

Bioassay for A-56268 (TE-031) and identification of its major metabolite, 14-hydroxy-6-O-methyl erythromycin

29 September 2017

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/1834012

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1128/AAC.35.7.1524

1 reference

16 August 2017

1 reference

PMC publication ID

245208

16 August 2017

1 reference

PMC publication ID

245208